MoneyWorks4Me

Biocon - Quaterly Results

21 Oct 2021 Evaluate
The sales moved down -34.86% to Rs. 3648.00 millions for the September 2021 quarter as compared to Rs. 5600.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2021 is Rs. -66.00 millions as compared to Net Profit of Rs. 950.00 millions of corresponding quarter ended September 2020The Operating Profit of the company witnessed a decrease to 173.00 millions from 1263.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3648.00 5600.00 -34.86 7475.00 10807.00 -30.83 20284.00 19884.00 2.01
Other Income 405.00 384.00 5.47 897.00 744.00 20.56 1502.00 2017.00 -25.53
PBIDT 173.00 1263.00 -86.30 900.00 2790.00 -67.74 4627.00 4877.00 -5.13
Interest 1.00 1.00 0.00 3.00 2.00 50.00 4.00 12.00 -66.67
PBDT 172.00 1262.00 -86.37 897.00 2788.00 -67.83 4623.00 6462.00 -28.46
Depreciation 265.00 264.00 0.38 525.00 521.00 0.77 1035.00 980.00 5.61
PBT -93.00 998.00 -109.32 372.00 2267.00 -83.59 3588.00 5482.00 -34.55
TAX -27.00 48.00 -156.25 147.00 469.00 -68.66 783.00 1119.00 -30.03
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -66.00 950.00 -106.95 225.00 1798.00 -87.49 2805.00 4363.00 -35.71
Equity 6003.00 6000.00 0.05 6003.00 6000.00 0.05 6000.00 6000.00 0.00
PBIDTM(%) 4.74 22.55 -78.97 12.04 25.82 -53.36 22.81 24.53 -7.00
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..